You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française


Cancer Type: Hematologic, Lymphoma - Non-Hodgkin's Intermediate Grade      Intent: Curative
Regimen Category: Evidence-informed
New Drug Funding Program
    Rituximab - As Part of the MATRix Regimen in Newly Diagnosed, Previously Untreated PCNSL

You might also be interested in